showing 1928 abstracts from year 2015
filter abstracts
| Details |
title |
year |
| Details |
G01 LIRAGLUTIDE IS EFFECTIVE IN THE HISTOLOGICAL CLEARANCE OF NON-ALCOHOLIC... |
2015 |
| Details |
G02 LEDIPASVIR/SOFOSBUVIR WITH RIBAVIRIN IS SAFE AND EFFICACIOUS IN DECOMPE... |
2015 |
| Details |
A PILOT STUDY... |
2015 |
| Details |
G04 ENGINEERED HBV-SPECIFIC T CELLS: DISENTANGLING ANTIVIRAL FROM KILLING C... |
2015 |
| Details |
G05 EXOME SEQUENCING OF 243 LIVER TUMORS IDENTIFIES NEW MUTATIONAL SIGNATUR... |
2015 |
| Details |
G06 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL OF TSU-6... |
2015 |
| Details |
O001 C-SALVAGE: GRAZOPREVIR (GZR; MK-5172), ELBASVIR (EBR; MK-8742) AND RIB... |
2015 |
| Details |
Conclusions:... |
2015 |
| Details |
O002 TREATMENT OF DECOMPENSATED HCV CIRRHOSIS IN PATIENTS WITH DIVERSE GENO... |
2015 |
| Details |
Conclusions:... |
2015 |
| Details |
O003 CAN HEPATITIS C TREATMENT BE SAFELY DELAYED? EVIDENCE FROM THE VETERAN... |
2015 |
| Details |
O004 ON-TREATMENT VIROLOGIC RESPONSE AND TOLERABILITY OF SIMEPREVIR, DACLAT... |
2015 |
| Details |
O005 RETREATMENT OF PATIENTS WHO FAILED 8 OR 12 WEEKS OF LEDIPASVIR/SOFOSBU... |
2015 |
| Details |
O006 C-SWIFT: GRAZOPREVIR/ELBASVIR + SOFOSBUVIR IN CIRRHOTIC AND NONCIRRHOT... |
2015 |
| Details |
O007 ALL ORAL HCV THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH DECOMPENSA... |
2015 |
| Details |
O008 EFFICACY AND SAFETY OF GRAZOPREVIR AND ELBASVIR IN HEPATITIS C GENOTYP... |
2015 |
| Details |
O009 A PROSPECTIVE STUDY OF HEPATITIS B REACTIVATION IN PATIENTS WITH PRIOR... |
2015 |
| Details |
O010 T AND B CELL RESPONSES AND PREVIOUS EXPOSURE TO HEPATITIS B VIRUS IN A... |
2015 |
| Details |
O011 A NATIONWIDE SURVEY OF HEPATITIS E VIRUS INFECTION IN LIVER TRANSPLANT... |
2015 |
| Details |
O012 HEPATITIS DELTA VIRUS CAN SURVIVE LIVER REGENERATION AND IS AMPLIFIED ... |
2015 |
1 2 3 4 5 6 7 8 ...97 Next